Clinical and economic outcomes of oral linezolid versus intravenous vancomycin in the treatment of MRSA-complicated, lower-extremity skin and soft-tissue infections caused by methicillin-resistant Staphylococcus aureus
J. Neal Sharpe, Eugene H. Shively, Hiram C. Polk Jr.Volume:
189
Année:
2005
Langue:
english
Pages:
429
DOI:
10.1016/j.amjsurg.2005.01.011
Fichier:
PDF, 123 KB
english, 2005